NRAS c.322G>A ;(p.D108N)

Variant ID: 1-115252318-C-T

NM_002524.4(NRAS):c.322G>A;(p.D108N)

This variant was identified in 5 publications

View GRCh38 version.




Publications:


JunB is a key regulator of multiple myeloma bone marrow angiogenesis.

Leukemia
Fan, Fengjuan F; Malvestiti, Stefano S; Vallet, Sonia S; Lind, Judith J; Garcia-Manteiga, Jose Manuel JM; Morelli, Eugenio E; Jiang, Qinyue Q; Seckinger, Anja A; Hose, Dirk D; Goldschmidt, Hartmut H; Stadlbauer, Andreas A; Sun, Chunyan C; Mei, Heng H; Pecherstorfer, Martin M; Bakiri, Latifa L; Wagner, Erwin F EF; Tonon, Giovanni G; Sattler, Martin M; Hu, Yu Y; Tassone, Pierfrancesco P; Jaeger, Dirk D; Podar, Klaus K
Publication Date: 2021-12

Variant appearance in text: NRAS: D108N
PubMed Link: 34007044
Variant Present in the following documents:
  • 41375_2021_1271_MOESM1_ESM.pdf
View BVdb publication page



Comprehensive omic characterization of breast cancer in Mexican-Hispanic women.

Nature Communications
Romero-Cordoba, Sandra L SL; Salido-Guadarrama, Ivan I; Rebollar-Vega, Rosa R; Bautista-Piña, Veronica V; Dominguez-Reyes, Carlos C; Tenorio-Torres, Alberto A; Villegas-Carlos, Felipe F; Fernández-López, Juan C JC; Uribe-Figueroa, Laura L; Alfaro-Ruiz, Luis L; Hidalgo-Miranda, Alfredo A
Publication Date: 2021-04-14

Variant appearance in text: NRAS: D108N
PubMed Link: 33854067
Variant Present in the following documents:
  • 41467_2021_22478_MOESM8_ESM.xlsx, sheet 9
View BVdb publication page



Formalin fixation increases deamination mutation signature but should not lead to false positive mutations in clinical practice.

Plos One
Prentice, Leah M LM; Miller, Ruth R RR; Knaggs, Jeff J; Mazloomian, Alborz A; Aguirre Hernandez, Rosalia R; Franchini, Patrick P; Parsa, Kourosh K; Tessier-Cloutier, Basile B; Lapuk, Anna A; Huntsman, David D; Schaeffer, David F DF; Sheffield, Brandon S BS
Publication Date: 2018

Variant appearance in text: NRAS: D108N
PubMed Link: 29698444
Variant Present in the following documents:
  • pone.0196434.s001.xlsx, sheet 1
  • pone.0196434.s001.xlsx, sheet 2
  • pone.0196434.s001.xlsx, sheet 3
View BVdb publication page



MEK inhibitors overcome resistance to BET inhibition across a number of solid and hematologic cancers.

Oncogenesis
Wyce, Anastasia A; Matteo, Jeanne J JJ; Foley, Shawn W SW; Felitsky, Daniel J DJ; Rajapurkar, Satyajit R SR; Zhang, Xi-Ping XP; Musso, Melissa C MC; Korenchuk, Susan S; Karpinich, Natalie O NO; Keenan, Kathryn M KM; Stern, Melissa M; Mathew, Lijoy K LK; McHugh, Charles F CF; McCabe, Michael T MT; Tummino, Peter J PJ; Kruger, Ryan G RG; Carpenter, Christopher C; Barbash, Olena O
Publication Date: 2018-04-20

Variant appearance in text: NRAS: D108N
PubMed Link: 29674704
Variant Present in the following documents:
  • 41389_2018_43_MOESM5_ESM.pdf
View BVdb publication page



LowMACA: exploiting protein family analysis for the identification of rare driver mutations in cancer.

Bmc Bioinformatics
Melloni, Giorgio E M GE; de Pretis, Stefano S; Riva, Laura L; Pelizzola, Mattia M; Céol, Arnaud A; Costanza, Jole J; Müller, Heiko H; Zammataro, Luca L
Publication Date: 2016-02-09

Variant appearance in text: NRAS: D108N
PubMed Link: 26860319
Variant Present in the following documents:
  • 12859_2016_935_MOESM2_ESM.xlsx, sheet 1
View BVdb publication page